4,299 results match your criteria: "Hospital Epidemiology[Affiliation]"

Outbreak with OXA-23-producing Acinetobacter baumannii in a COVID-19 ICU cohort: unraveling routes of transmission.

Antimicrob Resist Infect Control

October 2024

Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Petersgraben 4, Basel, CH-4031, Switzerland.

Article Synopsis
  • - An outbreak of a specific drug-resistant bacteria (OXA-23-producing Acinetobacter baumannii) occurred in ICU patients who also had COVID-19.
  • - The bacteria likely spread through contaminated surfaces, possibly from a shared positioning pillow used between patients.
  • - The rapid transmission may have been driven by healthcare workers' gloves and gowns becoming contaminated with respiratory secretions during patient care.
View Article and Find Full Text PDF

Purpose: Antiseptic bathing has garnered attention in an effort to reduce hospital-acquired infections. Previous studies have shown the efficacy of antiseptic bathing in high-risk environments, such as intensive care units (ICUs), using chlorhexidine. In this study we aimed to evaluate the effectiveness of octenidine as a potential alternative due to its established popularity and widespread use in Europe.

View Article and Find Full Text PDF

In this survey of infection prevention and control (IPC) professionals, we gauged knowledge, attitudes and institutional practices related to environmental sustainability and IPC. Overall, IPC professionals have not yet universally adopted measures to promote environmental sustainability. More research is needed around environmentally sustainable efforts that preserve patient safety in IPC.

View Article and Find Full Text PDF

Drug-drug interactions potential with the HIV-1 capsid inhibitor lenacapavir.

Expert Opin Drug Metab Toxicol

October 2024

Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

Article Synopsis
  • Lenacapavir is a groundbreaking HIV-1 capsid inhibitor, given subcutaneously every six months, primarily for salvage therapy but holds promise for future HIV treatment and prevention.
  • The review highlights lenacapavir's pharmacology, particularly focusing on its drug-drug interaction potential in treatment-experienced patients who often deal with multiple medications and health conditions.
  • Expert assessments indicate lenacapavir has an overall favorable drug interaction profile, with most evaluated comedications showing no significant interactions, although further research is needed to explore its effects in various populations and on specific drug interactions.
View Article and Find Full Text PDF

To see, or not to see… pathogens in virtual reality hand hygiene training.

Infect Control Hosp Epidemiol

October 2024

Department for Infectious Diseases and Hospital Epidemiology, University Hospital of Zurich, University of Zurich, Zurich, Switzerland.

Article Synopsis
  • ViRTUE is a virtual reality hand hygiene trainer that allows users to see how pathogens transfer during patient care, either in real-time or at the end of each level.
  • A study was conducted with first-year medical students to assess the impact of different visualization timings on their performance and immersion, with participants assigned to three different setups for viewing contagion events.
  • Results showed that students who only received "summary" visualizations performed better (fewer contaminations) and reported higher immersion compared to those who had "real-time" visuals, highlighting the need to pilot test VR training methods to optimize their effectiveness.
View Article and Find Full Text PDF

Introduction: Gram-negative bacillary bacteremia poses a significant threat, ranking among the most severe infectious diseases capable of triggering life-threatening sepsis. Despite the unambiguous involvement of neutrophils in this potentially fatal disease, there are limited data about the molecular signaling mechanisms, phenotype, and function of human neutrophils during the early phase of gram-negative bacillary bacteremia.

Methods: By using an unbiased proteomics and flow cytometry approach, we identified an antigen-presenting cell (APC)-like phenotype in human peripheral blood neutrophils (PMN) with MHC class II molecule expression in the early phase of bacteremia.

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the risk of developing infections from multidrug-resistant organisms (MDROs) like carbapenem-resistant Enterobacteriaceae (CRE), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant enterococci (VRE) in patients who are colonized versus those who are not.
  • - Conducted as a retrospective cohort study at a tertiary care facility, the research analyzed data from 19,134 active surveillance tests in 2021 and found that colonized patients had significantly higher risks of infection (risk ratios of 4.6 for CRE, 8.2 for MRSA, and 22 for VRE).
  • - The findings suggest that screening for these
View Article and Find Full Text PDF
Article Synopsis
  • Central line-associated bloodstream infections (CLABSI) have serious health impacts, and this study investigates their trends in incidence and pathogens over several years in a Swiss hospital.
  • Researchers analyzed data from 2016 to 2023, finding a stable CLABSI incidence density but an increase in the use of central lines.
  • The study highlighted a shift in the types of microorganisms causing CLABSI, with a rise in Enterococcus species and yeast, while coagulase-negative staphylococci decreased in prevalence.
View Article and Find Full Text PDF

Non-pharmaceutical infection prevention measures in nosocomial SARS-CoV-2 outbreaks: a retrospective multi-centre cohort study.

J Hosp Infect

January 2025

Department for Infection Control and Infectious Diseases, University Medical Center Göttingen, Georg-August University Göttingen, Göttingen, Germany.

Background: Hospital severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreaks are relevant for patients and healthcare systems within and beyond the pandemic.

Aim: To explore the characteristics of SARS-CoV-2 outbreaks and their infection prevention and control (IPC) measures during the different pandemic waves.

Methods: A comprehensive structured template for SARS-CoV-2 outbreaks was developed and filled out by six university hospitals.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores the impact of HIV on infectious disease events in kidney transplant recipients, showing that these patients have similar survival rates to HIV-negative individuals.
  • It analyzed data from the Swiss HIV Cohort Study and the Swiss Transplant Cohort Study, focusing on demographic and clinical characteristics since 2008.
  • The results indicated that while 70.8% of the HIV-positive patients experienced infectious disease events, HIV itself was not a significant risk factor for these events post-transplant.
View Article and Find Full Text PDF
Article Synopsis
  • In kidney transplant recipients, BK polyomavirus-associated nephropathy (BKPyVAN) is a significant risk for transplant loss, and reducing immunosuppression to manage BKPyV-DNAemia can also heighten the risk of graft rejection.
  • The CERTAIN study, involving 195 pediatric kidney transplant recipients, found that BKPyV-DNAemia significantly increased the risk of T cell-mediated rejection, development of donor-specific antibodies, and overall decline in graft function.
  • The findings suggest that careful monitoring and regular screening for donor-specific antibodies are essential when adjusting immunosuppressive therapy in patients with BKPyV-DNAemia to mitigate rejection risks.
View Article and Find Full Text PDF
Article Synopsis
  • Plasmids are small pieces of DNA in bacteria that can help or hurt them, depending on whether they're useful or costly.
  • Bacteria have special defense systems, like RM and CRISPR-Cas, that can stop harmful plasmids but might let useful ones stick around.
  • Even though some expensive plasmids might disappear over time, bacteria can still find ways to keep them around by using clever tricks to escape detection.
View Article and Find Full Text PDF

Genomic Surveillance for Enhanced Healthcare Outbreak Detection and Control.

medRxiv

September 2024

Microbial Genomic Epidemiology Laboratory, Center for Genomic Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Article Synopsis
  • Current outbreak detection methods in hospitals are inadequate on their own; a new program called the Enhanced Detection System for Healthcare-associated Transmission (EDS-HAT) uses real-time genomic surveillance to identify outbreaks.
  • The study, conducted at UPMC Presbyterian Hospital from November 2021 to October 2023, involved weekly whole genome sequencing of bacterial isolates, leading to the identification of 172 outbreaks and successful intervention strategies that prevented further transmission in over 95% of cases.
  • Results revealed significant benefits: 62 infections were avoided, translating to over $1 million in gross savings and a net savings of nearly $700,000, showing that integrating genomic surveillance can greatly enhance infection control and patient safety.
View Article and Find Full Text PDF

Cardiac Repair after Myocardial Infarction is Controlled by a Complement C5a Receptor 1-Driven Signaling Cascade.

Thromb Haemost

October 2024

Institute for Transplantation Diagnostics and Cell Therapeutics, University Hospital and Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Article Synopsis
  • Cardiac repair is super important after a heart attack to help the heart heal and work better, and scientists are studying a specific receptor called C5aR1.
  • Researchers found that when the C5aR1 receptor is not present, it helps reduce the damage to the heart and improve its function after a heart attack.
  • The study suggests that by blocking the C5aR1 receptor, we might be able to make the heart heal better after a heart attack, which can help save lives.
View Article and Find Full Text PDF

A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study.

Trials

October 2024

Division of Infectious Diseases and Hospital Epidemiology, Children's Research Center, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, Zurich, CH-8032, Switzerland.

Article Synopsis
  • * The MYTHIC Study is designed as a rigorous trial involving 13 Swiss pediatric centers, comparing macrolide treatment to placebo in children aged 3-17 diagnosed with pneumonia, using precise tests to confirm M. pneumoniae infection.
  • * The main goals are to assess the time to stabilize vital signs and determine any changes in patient care within 28 days, with an aim to show that the placebo is not significantly less effective than macrolide treatment in managing this infection.
View Article and Find Full Text PDF

Inhibition of biofilm by and .

mSphere

October 2024

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University Zurich, Zurich, Switzerland.

Article Synopsis
  • The study investigates the anti-biofilm effects of cell-free supernatants from two probiotic bacterial strains on a human pathobiont responsible for serious infections, including pharyngotonsillitis and necrotizing fasciitis.
  • It finds that these supernatants significantly reduce the survival of both planktonic and biofilm forms of the pathogen, particularly affecting already established biofilms more intensely, suggesting the involvement of glycolipid compounds in this antimicrobial action.
  • The results highlight the need for new therapeutic strategies against biofilm-associated infections, particularly for vulnerable populations, and aim to enhance understanding of lactobacillus properties that could lead to innovative treatment options.
View Article and Find Full Text PDF

Background: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract, but the molecular mechanisms underlying IBD are incompletely understood. In this study, we explored the role and regulating mechanism of otubain 2 (OTUB2), a deubiquitinating enzyme, in IBD.

Methods: To study the function of OTUB2 in IBD, we generated Otub2 mice and treated them with dextran sulfate sodium (DSS) to induce experimental colitis.

View Article and Find Full Text PDF

Background And Rationale: Methicillin resistant Staphylococcus aureus (MRSA) colonization increases the risk of MRSA infection. Detecting MRSA colonization can influence postoperative outcomes and prolong hospital stay. The conventional standard culture method for detecting MRSA colonization has limitations in terms of sensitivity and turnaround time.

View Article and Find Full Text PDF

Comprehensive Herpesviruses Antiviral drug Resistance Mutation Database (CHARMD).

Antiviral Res

November 2024

Centre National de Référence des Herpèsvirus, CHU Limoges, Limoges, France; UF8843 Génomique médicale, CHU Limoges, Limoges, France; Inserm, U1092, RESINFIT, Université de Limoges, Limoges, France; FHU SUPORT, CHU Limoges, Limoges, France. Electronic address:

A comprehensive and accessible Herpesvirus drug resistance database was designed to serve as an international reference for diagnosis and clinical studies. This database available at https://www.unilim.

View Article and Find Full Text PDF
Article Synopsis
  • Helicobacter pylori (H. pylori) is a type of bacteria that can live in the human stomach and make people sick by causing infections.
  • This bacteria has clever ways to hide from the body's immune system, such as changing its surface to avoid detection and blocking important signals that help fight infections.
  • Scientists used a special imaging technique on mice to see how immune cells, like neutrophils and macrophages, react to H. pylori in real-time, which helps them understand how infections work better.
View Article and Find Full Text PDF

Immediate-use steam sterilization (IUSS) shortens the time of sterilization but may increase the risk of surgical site infection (SSI). Among 23,919 procedures with 416 (1.7%) procedures resulting in SSI, IUSS was associated with a 1.

View Article and Find Full Text PDF

Background: This paper describes an outbreak of Ralstonia mannitolilytica infection declared at our facility between January-2021 and January-2022.

Methods: To identify the source of the outbreak, we applied widespread epidemiological investigations and infection control measures, including device isolation, environmental sampling, and pulsed-field gel electrophoresis typing.

Results: Thirty-six cases of R mannitolilytica infection were identified, mostly adults (78%) and males (75%).

View Article and Find Full Text PDF

The Fungus Among Us: Proactively Preventing Candida auris Transmission via Ultrasound Transducers.

J Ultrasound Med

January 2025

Division of Infection Control/Hospital Epidemiology, Silverman Institute for Health Care Quality and Safety, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

View Article and Find Full Text PDF

Colonization with resistant bacteria in hospital employees: an epidemiological surveillance and typing study.

Antimicrob Agents Chemother

November 2024

Division of Infectious Diseases, Infection Prevention and Travel Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland.

The objective of this study was to determine the prevalence, molecular epidemiology, and risk factors for gut colonization with extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), carbapenemase-producing Enterobacterales (CPE), and vancomycin-resistant enterococci (VRE) in healthcare workers (HCWs). In September/October 2022, we performed a cross-sectional study among HCW from 14 institutions in Northeastern Switzerland. HCWs reported risk factors for antimicrobial resistance (covering the last 12-24 months) and provided rectal swabs.

View Article and Find Full Text PDF

Fusariosis in the Sphere.

Open Forum Infect Dis

September 2024

Hospital Médica Sur, Infectious Diseases and Hospital Epidemiology, Mexico City, Mexico.

In 2012, the US Centers for Disease Control and Prevention reported a fungal meningitis outbreak due to , caused by methylprednisolone administration. Twelve years later, an iatrogenic outbreak of meningitis was documented in Mexico after epidural anesthesia.

View Article and Find Full Text PDF